Admission Date:  [**2189-9-11**]              Discharge Date:   [**2189-9-17**]  Date of Birth:  [**2122-11-30**]             Sex:   F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 12131**] Chief Complaint: pericardial tamponade  Major Surgical or Invasive Procedure: cardiac cath with pericardiocentesis for pericardial effusion/tamponade pericardial window  History of Present Illness: 6yoF with Stage IV non-small cell lung ca metastatic to brain s/p 2 cyberknife treatments and also with L pleurex and severe Parkinson's disease presents s/p urgent pericardiocentesis after echocardiogram showed tamponade.
On review of systems, she (and her family) denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools.
Cardiac review of systems is notable for absence of paroxysmal nocturnal dyspnea, orthopnea, palpitations, syncope or presyncope.
[**2189-9-11**] 01:08PM   VoidSpec-CLOTTED SP [**2189-9-11**] 12:45PM OTHER BODY FLUID  TOT PROT-3.4 GLUCOSE-110 LD(LDH)-265 AMYLASE-581 ALBUMIN-2.1 [**2189-9-11**] 12:45PM OTHER BODY FLUID  WBC-1700* HCT-4.5* POLYS-96* LYMPHS-3* MONOS-1* [**2189-9-11**] 12:15PM   GLUCOSE-104* UREA N-26* CREAT-0.6 SODIUM-137 POTASSIUM-4.1 CHLORIDE-104 TOTAL CO2-23 ANION GAP-14 [**2189-9-11**] 12:15PM   estGFR-Using this [**2189-9-11**] 12:15PM   WBC-14.6*# RBC-4.20 HGB-13.4 HCT-38.9 MCV-93 MCH-31.9 MCHC-34.5 RDW-16.4* [**2189-9-11**] 12:15PM   PLT COUNT-171 [**2189-9-11**] 12:15PM   PT-11.4 INR(PT)-1.0 [**2189-9-14**] 06:47AM URINE Blood-LG Nitrite-NEG Protein-100 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-TR [**2189-9-14**] 06:47AM URINE RBC->182* WBC-3 Bacteri-NONE Yeast-NONE Epi-0 [**2189-9-11**] 12:45PM Pericardial FLUID TotProt-3.4 Glucose-110 LD(LDH)-265 Amylase-581 Albumin-2.1 [**2189-9-11**] 12:45PM Pericardial FLUID WBC-1700* Hct,Fl-4.5* Polys-96* Lymphs-3* Monos-1* .
CARDIAC CATH: Hemodynamic Measurements (mmHg) Baseline Site	Sys	[**Last Name (un) 6043**]	End	Mean	A Wave	V Wave	HR RA      			20	23	20	87 RV      34	17	20				84 PCW     			28	30	32	69 PA      34	21		22			85 PP      			20			81  Contrast Summary Contrast	Total (ml) Omnipaque (300 mg/ml)	2  Radiology Summary Total Cine Runs	 Fluoro Time (minutes)	3.00 Total IRP Dosage (mGy)	27  Findings ESTIMATED blood loss: <100 cc Hemodynamics (see above):  Blunted y descent.
Interventional details Accessed pericardial space with combination of echocardiography, pressure and fluoroscopic guidance using a micropuncture needle.
Exchanged for an Amplatz stiff wire and using a series of 5,6,7,8 French Dilators were able to place an 8 French drainage catheter and remove 120 cc of bloody fluid.
[**2189-9-17**] 08:00AM BLOOD WBC-6.7 RBC-3.92* Hgb-12.3 Hct-36.9 MCV-94 MCH-31.5 MCHC-33.5 RDW-16.3* Plt Ct-189 [**2189-9-17**] 08:00AM BLOOD Glucose-114* UreaN-26* Creat-0.6 Na-138 K-4.1 Cl-105 HCO3-24 AnGap-13 [**2189-9-17**] 08:00AM BLOOD Albumin-3.1* Calcium-7.9* Phos-2.2* Mg-2.3  Brief Hospital Course: 66yoF with stage IV metastatic nonsmall cell lung ca and severe Parkinson's Disease p/w cardiac tamponade s/p pericardiocentesis and drain placement.
A transcutaneous drainage procedure was preformed with 150 cc of serosanginous fluid removal and decrease in the pulsus to 15 mg Hg.
Patient was later sent for difinitive pericardial window by CT surgery and tolerated the procedure well.
# Metastatic NSCLC:  patient was admitted with a known diagnosis of stage IV NSCLC with metastatis to the brain, a large left sided effusion vs collapse on CXR and was s/p cyberknife therapy.
Patient was continued on a dexamethasone taper for her reccent cyberknife procedure.
# Hypoxic respiratory failure: Patient had known NSCLC and was noted to be hypoxic to the low 90s on addmission though not on home oxygen.
Patient had plurex catheter in on admisison and IP was consulted who d/c'd the tube as it had not had any output in several days.
She was continued on her outpatient regimen of Amantadine, pramipexole and simemet.
# Hep B: patient continued on home entecavir.
Transitional issues: -cytology and pericardial biopsy were pending at time of transfer -pharmacy has raised concern that dexamethasone and erlotinib have possible interactions and dex taper may need to be shortened.
Medications on Admission: ALENDRONATE -  (Prescribed by Other Provider) - Dosage uncertain AMANTADINE - 100 mg Capsule - 1 Capsule by mouth three times a day BENZONATATE -  (Prescribed by Other Provider) - Dosage uncertain CARBIDOPA-LEVODOPA - 25 mg-100 mg Tablet - 0.5 Tablets by mouth five times a day CODEINE-GUAIFENESIN - 100 mg-10 mg/5 mL Liquid - 1 tsp by mouth every eight (8) hours as needed for cough DEXAMETHASONE -  (Dose adjustment - no new Rx) - 4 mg Tablet - 1 (One) Tablet(s) by mouth twice a day-Start 2 days prior to Cyberknife treatments.
Stop taking Decadron after your dose on [**2189-9-24**].
ENTECAVIR [BARACLUDE] - 0.5 mg Tablet - 1 Tablet(s) by mouth daily take medication 2 hours before and after meal HOME SERVICES EVALUATION -   - by Spring Well Company LEVETIRACETAM -  (Dose adjustment - no new Rx) - 500 mg Tablet - 1 (One) Tablet(s) by mouth twice a day-Start 2 days prior to Cyberknife treatment.
Continue taking Keppra as prescribed for 7 days after your CyberKnife treatment.
PRAMIPEXOLE [MIRAPEX] - 0.5 mg Tablet - 1 Tablet by mouth five times per day RANITIDINE HCL -  (Dose adjustment - no new Rx) - 150 mg Tablet - 1 (One) Tablet(s) by mouth twice a day-Start 2 days prior to Cyberknife treatment.
Continue taking Zantac as prescribed as long as [**Known firstname **] are taking Decadron.
Discharge Medications: 1. amantadine 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
2. benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
3. carbidopa-levodopa 25-100 mg Tablet Sig: 0.5 Tablet PO 5X/DAY (5 Times a Day).
4. dexamethasone 2 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
5. entecavir 0.5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
6. pramipexole 0.25 mg Tablet Sig: 0.5 Tablet PO 5x/Day ().
7. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily).
8. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
9. erlotinib 25 mg Tablet Sig: Six (6) Tablet PO DAILY (Daily).
[**Known firstname **] had a procedure to drain this fluid followed by a surgery to help prevent reaccumulation of this fluid.
While [**Known firstname **] were in the hospital [**Known firstname **] were started on a chemotherapy that [**Known firstname **] will need to take at home.
